The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Jacques Rousseau who was the cardiologist who led the women's health initiative had published an article and I don't remember which Mary might be sick 1996 basically saying it's time to bring the HRT bandwagon to a halt the HRT bandwagon this has too many women are on HRT this is not a good thing and it's time to it's time to stop the rolling bandwagon
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Jacques Rousseau who was the cardiologist who led the women's health initiative had published an article and I don't remember which Mary might be sick 1996 basically saying it's time to bring the HRT bandwagon to a halt the HRT bandwagon this has too many women are on HRT this is not a good thing and it's time to it's time to stop the rolling bandwagon so he himself clearly had some kind of bias going into the direction of this study
For symptomatic perimenopausal women under 60, hormone replacement therapy reduces all-cause mortality.
The breast-cancer risk attributed to HRT in the original WHI trial was overstated and the timing window matters most.